Angels Share In Biotech Rewards, But Rarely In Drug Discovery
This article was originally published in The Pink Sheet Daily
Executive Summary
New data shows an uptick in start-up investment by individuals in young biotech and health care companies, as the contracting venture capital industry shies away from early-stage investing. But angels still avoid companies with high costs, particularly those associated with clinical and regulatory paths.